Live Breaking News & Updates on Ku Leuven Gemma Frisius

Stay updated with breaking news from Ku leuven gemma frisius. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rewind Therapeutics raises funding to further lead programme into clinical development

Rewind Therapeutics has raised further funding that has seen Sunstone Life Science Ventures joining as a new investor. The funding round has seen participation of current investors Boehringer Ingelheim Venture Fund, M. Ventures, PMV, Gemma Frisius Fonds, and CD3/ KU Leuven. ....

Anja Harmeier , Ku Leuven Gemma Frisius , Claus Andersson , Ku Leuven Centre For Drug Design , Boehringer Ingelheim Venture Fund , Gemma Frisius Fonds , Sunstone Life Science Ventures , Merck Ventures , Participatiemaatschappij Vlaanderen , Drug Design , Rewind Therapeutics ,

Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

/PRNewswire/ Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for multiple. ....

Anja Harmeier , Pureos Bioventures , Ku Leuven Gemma Frisius , Jim Van , Evelyn Mccormack , Ku Leuven Centre For Drug Design , Institute Of Biochemistry At Freie Universit , Life Sciences , Boehringer Ingelheim Venture Fund , Roche Venture Fund , Rewind Therapeutics , Chief Executive , Vico Therapeutics , Corlieve Therapeutics , River Renal , Investment Director , Vivet Therapeutics , Freie Universit , Instituto De Empresa , Executive Chairman , Drug Design , ஜிம் வேன் , வாழ்க்கை அறிவியல் , போஹெரிங்கர் இஂகல்‌ஹைம் துணிகர நிதி , ரோச் துணிகர நிதி , முன்னாடி சிகிச்சை ,